Your Advocates Ltd’s Amgen AMGN Stock Holding History

Your Advocates Ltd’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.52K	Hold	18	–	–	﹤0.01%	139
2026 Q1	$6.33K	Hold	18	–	–	﹤0.01%	141
2025 Q4	$5.89K	Hold	18	–	–	﹤0.01%	145
2025 Q3	$5.08K	Hold	18	–	–	﹤0.01%	143
2025 Q2	$5.03K	Hold	18	–	–	﹤0.01%	136
2025 Q1	$5.61K	Hold	18	–	–	﹤0.01%	133
2024 Q4	$4.69K	Hold	18	–	–	﹤0.01%	138
2024 Q3	$5.8K	Hold	18	–	–	﹤0.01%	144
2024 Q2	$5.62K	Hold	18	–	–	﹤0.01%	140
2024 Q1	$5.12K	Hold	18	–	–	﹤0.01%	145
2023 Q4	$5.18K	Hold	18	–	–	﹤0.01%	137
2023 Q3	$4.84K	Hold	18	–	–	﹤0.01%	150
2023 Q2	$4K	Buy	+18	New	+$4.18K	﹤0.01%	182

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Your Advocates Ltd's AMGN Position: Q2 2026 in Review

Your Advocates Ltd held its Amgen (AMGN) position steady in Q2 2026 at 18 shares worth $6.52K. The position accounts for ﹤0.01% of the portfolio, ranked #139.

Your Advocates Ltd first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Your Advocates Ltd held 18 shares of Amgen worth $6.52K as of Q2 2026.
Your Advocates Ltd left its Amgen share count unchanged in Q2 2026.
Amgen made up ﹤0.01% of Your Advocates Ltd's portfolio in Q2 2026, its #139 holding.
Your Advocates Ltd first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Your Advocates Ltd's 13F filing for Q2 2026, filed 5 Aug 2026.